Recent TGTX Stock Price | TGTX Stock Predictions | |
$29.04 | +29.86% |
$37.71 |
Recent TGTX Analyst Ratings Breakdown, Making TGTX Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 6 | 6 | 7 | 6 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 1 | 1 | 1 | 1 |
Sell ratings: | 1 | 1 | 1 | 1 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.63 | 1.63 | 1.56 | 1.63 |
For the TGTX stock predictions from the analysts covering TG Therapeutics Inc, we have collected all of the individual TGTX stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 7 different analysts covering TGTX (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since TGTX stock predictions may vary widely, another useful metric to consider is the median TGTX stock prediction, which represents the price at which half of the analysts
made TGTX stock predictions that were higher and half made TGTX stock predictions that were lower. This makes for a different take on the TGTX stock predictions out there, as compared to average or mean.
And that median across all the individual TGTX stock predictions was: $43.0 as of 2025-01-24.
The very highest of the TGTX stock predictions for one year price target was $55.0, while the very lowest of the TGTX stock predictions in the analyst group was
$10.0 (with a standard deviation of $16.131). Get the latest Zacks research report on TGTX — FREE
Find out: TGTX next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
TNC Stock Predictions
MPLX Stock Predictions
VUZI Stock Predictions
MRBK Stock Predictions
LPL Stock Predictions
CBB Stock Predictions
MSGN Stock Predictions
FTS Stock Predictions
EXTR Stock Predictions
|
|
Buy (3.37 out of 4) 52nd percentile
(ranked higher than approx. 52% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |